Marco Ventin, General Surgery Resident at UC Irvine, shared a post on X about a recent paper he co-authored with colleagues published in JAMA Surgery:
“Beyond excited to see our work in JAMA Surgery.
We developed a risk score for recurrence and survival in LN–negative PanNETs, identifying patients at low, moderate, and high risk to guide risk-adapted postoperative surveillance and management.”
Title: Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors
Authors: Marco Ventin, Shahrzad Arya, Liti Zhang, Alexandra Gangi, Carlos Fernandez del-Castillo, Motaz Qadan, Andrew E. Hendifar, Giulia Cattaneo, Luigi Liguori, Arsen Osipov, Francesco Sabbatino, Nicholas N. Nissen, Kambiz Kosari, Keith D. Lillemoe, Alice C. Wei, Jin He, Amer H. Zureikat, Cristina R. Ferrone
Read the Full Article in JAMA Surgery.
More posts about Pancreatic Neuroendocrine Tumors on OncoDaily.